Opko Health (OPK) Other financing activities (2014 - 2015)

Opko Health's (OPK) quarterly Other financing activities came in at -$691000.0 in Q2 2015, down 187.36% on a QoQ basis from $791000.0 in Q1 2015.

Opko Health (OPK) Other financing activities (2014 - 2015) Analysis & Trends

Opko Health (OPK) has 2 years of Other financing activities data on file, last reported at -$691000.0 in Q2 2015.

Quarterly Other financing activities changed N/A year-over-year to -$691000.0 in Q2 2015, while the trailing twelve-month figure through Mar 2016 was -$691000.0 (down 119.82% YoY) and the FY2015 annual result came in at $100000.0, down 96.29% from the prior year.
Other financing activities slipped to -$691000.0 in Q2 2015, from $791000.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $2.7 million in Q4 2014 to a low of -$691000.0 in Q2 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn
10	Opko Health	1.13 Bn	824.59 Mn	80.02 Mn

Download Data